Related Experiment Videos
Repeated naloxone administration in schizophrenia.
Psychiatry Research
|August 1, 1984
Summary
This study found that naloxone did not improve symptoms in schizophrenic patients. Placebo injections showed a slight, temporary reduction in symptoms, unlike naloxone treatment.
Area of Science:
- Neuroscience
- Psychiatry
Background:
- Schizophrenia is a complex psychiatric disorder.
- The role of endorphins in schizophrenia is hypothesized.
Purpose of the Study:
- To investigate the efficacy of naloxone in treating schizophrenic symptoms.
- To explore the link between endorphin activity and schizophrenia.
Main Methods:
- A double-blind, placebo-controlled study.
- 10 schizophrenic patients received subcutaneous naloxone (20 mg) or placebo.
- Symptoms were monitored over 4 consecutive days.
Main Results:
- No significant clinical improvement was observed with naloxone treatment.
- A slight, statistically significant decrease in symptomatology occurred after placebo injections.
- This placebo effect was not observed with naloxone.
Conclusions:
- Naloxone did not demonstrate efficacy in reducing schizophrenic symptoms in this study.
- The findings do not support the hypothesis of increased endorphin activity contributing to schizophrenia symptoms.
- Further research is needed to understand the neurobiology of schizophrenia.